Brown Financial Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$481K Sell
1,328
-1
-0.1% -$342 0.17% 120
2026
Q1
$468K Sell
1,329
-160
-11% -$57K 0.18% 112
2025
Q4
$487K Sell
1,489
-27
-2% -$8.56K 0.18% 109
2025
Q3
$428K Buy
1,516
+29
+2% +$8.41K 0.16% 120
2025
Q2
$415K Sell
1,487
-13
-0.9% -$3.68K 0.16% 124
2025
Q1
$467K Sell
1,500
-132
-8% -$39K 0.19% 107
2024
Q4
$425K Buy
1,632
+362
+29% +$107K 0.17% 115
2024
Q3
$409K Sell
1,270
-1,147
-47% -$375K 0.17% 122
2024
Q2
$755K Buy
+2,417
New +$710K 0.34% 89

Other funds holding AMGN

Brown Financial Advisors's AMGN Position: Q2 2026 in Review

Brown Financial Advisors reduced its Amgen (AMGN) stake by 0.08% in Q2 2026, selling an estimated $342 and leaving 1,328 shares worth $481K. The position accounts for 0.17% of the portfolio, ranked #120.

Brown Financial Advisors first reported a position in AMGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $755K in Q2 2024. 3,158 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Brown Financial Advisors held 1,328 shares of Amgen worth $481K as of Q2 2026.
  • Brown Financial Advisors sold 1 Amgen share in Q2 2026, an estimated $342.
  • Amgen made up 0.17% of Brown Financial Advisors's portfolio in Q2 2026, its #120 holding.
  • Brown Financial Advisors first reported a position in Amgen in Q2 2024 and has held it in 9 quarters since.
  • Brown Financial Advisors's Amgen position peaked at $755K in Q2 2024.
  • 3,158 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Brown Financial Advisors's 13F filing for Q2 2026, filed 26 Aug 2026.